|
Miralles-López J.C., Bravo-Gutierrez F.J., Andújar-Espinosa R., Castilla-Martínez M., Díaz-Chantar C., Ramírez-Hernández M., Cabrejos-Perotti S., Avilés-Inglés M.J., Ibarra-Calabuig I., Reyes-Cotes M.H., Pajarón-Fernández M.J., Bernabéu-Mora R., Alcalde-Rumayor C., Alemany-Francés M.L., Valverde-Molina J., Pérez-Fernández V. Real-life effectiveness of tezepelumab in severe asthma. Allergologia et immunopathologia. 2025. 53:163-173. 10.15586/aei.v53i2.1326
AÑO: 2025; IF: 2.5
|
|
Moreno-Villares J.M., Andrade-Platas D., Soria-López M., Colomé-Rivero G., Catalan Lamban A., Martinez-Figueroa M.G., Espadaler-Mazo J., Valverde-Molina J. Comparative efficacy of probiotic mixture Bifidobacterium longum KABP042 plus Pediococcus pentosaceus KABP041 vs. Limosilactobacillus reuteri DSM17938 in the management of infant colic: a randomized clinical trial. European Journal of Pediatrics. December 2024. 183:5371-5381. 10.1007/s00431-024-05806-x
AÑO: 2024; IF: 3.0
|
|
Miralles-López J.C., Alvarez-Gutiérrez F.J., Delgado-Romero J., Quirce S., Soto-Campos J.G., Andújar-Espinosa R., Cabrejos-Perotti S., Castilla-Martínez M., Flores-Martín I., Pajarón-Fernández M.J., Valverde-Molina J. Disease Modification in Asthma: Are We on the Right Way? A Multidisciplinary Expert Delphi Consensus (MODIASTHMA Consensus). Journal of Asthma and Allergy. 2024. 17:1163-1171. 10.2147/JAA.S488764
AÑO: 2024; IF: 3.7
|
|
Bravo-Gutierrez FJ, Miralles-Lopez JC, Valverde-Molina J, Alemany Frances ML, Andujar-Espinosa R, Castilla-Martinez M, Aviles-Ingles MJ, Mora-Gonzalez A, Pajaron-Fernandez MJ, Cabrejos-Perotti S, Meseguer-Arce J, Flores Martin I, Perez-Fernandez V; RE-ASGRAMUR Group. Effectiveness of Mepolizumab in Patients with Severe Eosinophilic Asthma with/without Nasal Polyposis: A Real-Life Study. Int Arch Allergy Immunol. 2024;185(3):253-259. doi: 10.1159/000534902. Epub 2023 Nov 30. PubMed PMID: 38035559.
AÑO: 2024; IF: 2.5
|
|
Miralles-Lopez JC, Andujar-Espinosa R, Bravo-Gutierrez FJ, Cabrejos-Perotti S, Ramirez-Hernandez M, Diaz-Chantar C, Pajaron-Fernandez MJ, Valverde-Molina J, Perez-Fernandez V; RE-ASGRAMUR GROUP. Tezepelumab in Patients With Severe Asthma: Response at 3 Months. J Investig Allergol Clin Immunol. 2024 Nov 25:0. doi: 10.18176/jiaci.1041. Online ahead of print. No abstract available. PubMed PMID: 39584417.
AÑO: 2024; IF: 6.1
|